首页> 外文期刊>Clinical & translational oncology : >Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: Are noncoplanar beam angles necessary?
【24h】

Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: Are noncoplanar beam angles necessary?

机译:不可调节的胰腺癌的调强放疗(IMRT)治疗的束角选择:非共面束角是否必要?

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: External beam radiation therapy with concurrent chemotherapy (CRT) is widely used for the treatment of unresectable pancreatic cancer. Noncoplanar (NCP) 3D conformal radiotherapy (3DCRT) and coplanar (CP) IMRT have been reported to lower the radiation dose to organs at risk (OARs). The purpose of this article is to examine the utility of noncoplanar beam angles in IMRT for the management of pancreatic cancer. Materials and methods: Sixteen patients who were treated with CRT for unresectable adenocarcinoma of the pancreatic head or neck were re-planned using CP and NCP beams in 3DCRT and IMRT with the Varian Eclipse treatment planning system. Results: Compared to CP IMRT, NCP IMRT had similar target coverage with slightly increased maximum point dose, 5,799 versus 5,775 cGy (p = 0.008). NCP IMRT resulted in lower mean kidney dose, 787 versus 1,210 cGy (p < 0.0001) and higher mean liver dose, 1,208 versus 1,061 cGy (p < 0.0001). Also, NCP IMRT resulted in similar mean stomach dose, 1,257 versus 1,248 cGy (p = 0.86) but slightly higher mean small bowel dose, 981 versus 866 cGy (p < 0.0001). Conclusions: The NCP IMRT was able to significantly decrease bilateral kidney dose, but did not improve other dose-volume criteria. The use of NCP beam angles is preferred only in patients with risk factors for treatment-related kidney dysfunction.
机译:背景与目的:伴有联合化疗(CRT)的外照射疗法被广泛用于治疗不可切除的胰腺癌。据报道,非共面(NCP)3D适形放射疗法(3DCRT)和共面(CP)IMRT可以降低对处于危险中的器官(OAR)的辐射剂量。本文的目的是研究IMRT中非共面光束角在胰腺癌管理中的实用性。材料和方法:用Varian Eclipse治疗计划系统在3DCRT和IMRT中使用CP和NCP射线重新计划了16例接受CRT治疗的无法切除的胰头或颈部腺癌患者。结果:与CP IMRT相比,NCP IMRT具有相似的靶标覆盖范围,最大点剂量略有增加,分别为5,799 cGy和5,775 cGy(p = 0.008)。 NCP IMRT导致平均肾脏剂量较低,分别为787和1,210 cGy(p <0.0001)和较高的平均肝脏剂量1,208与1,061 cGy(,p <0.0001)。同样,NCP IMRT产生的平均胃剂量相似,分别为1,257 cGy和1,248 cGy(p = 0.86),但平均小肠剂量为981 cgy相对于866 cGy(p <0.0001)。结论:NCP IMRT能够显着降低双侧肾脏的剂量,但不能改善其他剂量标准。仅在具有与治疗相关的肾功能不全的危险因素的患者中,才优选使用NCP束角。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号